NCT06484881

Clinical Study of Probiotic Treatment for Androgenetic Alopecia

• Status: Withdrawn
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Applied Biology, Inc. · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of the study is to assess the efficacy of DA-001 as an oral supplement for treatment of female pattern hair loss.

Detailed description

DA-001 is a botanical supplement demonstrated natural ingredients known to exert anti-androgen effects. The ingredients were tested in-vitro and have demonstrated the anti-androgen effect. This study aims to compare DA-001 to topical minoxidil in the treatment of female pattern hair loss (also known as androgenetic alopecia).

Conditions

• Androgenetic Alopecia
• Female Pattern Baldness

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Daniel Alain Probiotic Treatment for Androgenetic Alopecia	Probiotic
DRUG	Topical minoxidil 5%	Topical minoxidil 5%

Timeline

• Start date: 2024-09-15
• Primary completion: 2024-10-10
• Completion: 2024-10-10
• First posted: 2024-07-03
• Last updated: 2024-10-15